Ani Pharmaceuticals (ANIP) EBIT (QoQ) (2011 - 2026)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) EBIT (QoQ) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.55 Bn | 38.89 Bn | 2.15 Bn |
| 2 | Viatris | 19.15 Bn | 18.26 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.87 Bn | 9.70 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.32 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 401.76 Mn | 360.51 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.04% |
| Mar 31, 2026 | 11.85% |
| Dec 31, 2025 | -4.06% |
| Sep 30, 2025 | 160.87% |
| Jun 30, 2025 | -46.96% |
| Mar 31, 2025 | 698.31% |
| Dec 31, 2024 | 78.66% |
| Sep 30, 2024 | -496.96% |
| Jun 30, 2024 | -74.55% |
| Mar 31, 2024 | 201.99% |
| Dec 31, 2023 | -62.53% |
| Sep 30, 2023 | 44.72% |
| Jun 30, 2023 | 25.34% |
| Mar 31, 2023 | 443.68% |
| Dec 31, 2022 | 136.44% |
| Sep 30, 2022 | 61.32% |
| Jun 30, 2022 | 32.73% |
| Mar 31, 2022 | 19.09% |
| Dec 31, 2021 | -566.00% |
| Sep 30, 2021 | 77.10% |